Download PDF
Pneumologie 2009; 63(1): 14-22
DOI: 10.1055/s-2008-1038292
Serie: Infektiologie

© Georg Thieme Verlag KG Stuttgart · New York

Nachweis von Atemwegsviren – Wie, warum, wann und wo?

Detection of Respiratory Viruses – How, When, Where and Why?G.  Rohde1 , C.  Drosten2 , I.  Borg1 , B.  Hauptmeier1 , F.  Ringshausen1 , G.  Schultze-Werninghaus1 , K.  Überla3
  • 1Medizinische Klinik III – Pneumologie, Allergologie und Schlaf- und Beatmungsmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Bochum
  • 2Institut für Virologie, Universitätsklinikum Bonn
  • 3Abteilung für Molekulare und Medizinische Virologie, Ruhr-Universität Bochum
Further Information

Publication History

Publication Date:
09 January 2009 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Atemwegsviren sind für die überwiegende Mehrzahl aller so genannten Erkältungskrankheiten und grippalen Infekte in der kalten Jahreszeit, akuter respiratorischen Erkrankungen im Kindesalter sowie akuter Exazerbationen von Asthma bronchiale und chronisch obstruktiver Lungenerkrankungen (COPD) verantwortlich und spielen eine nicht zu vernachlässigende Rolle bei der ambulant erworbenen Pneumonie. Leider ist der Nachweis von Atemwegsviren bis heute schwierig. In dieser Übersicht werden daher die wesentlichen Untersuchungsverfahren vorgestellt und der aktuelle Stand des Wissens über die klinische Bedeutung von Atemwegsviren bei den unterschiedlichen Erkrankungen präsentiert.

Abstract

Respiratory viruses trigger the majority of common colds, acute respiratory illnesses in children during the cold season as well as acute exacerbations of asthma and chronic obstructive pulmonary disease. They also play a role in community acquired pneumonia. Unfortunately their detection is still difficult. The aim of this review is therefore to introduce the methods of detection and to present the current knowledge of the clinical role of respiratory viruses in different diseases.

Literatur

  • 1 Modrow S, Falke D, Truyen U. Labormethoden zum Nachweis von Virusinfektionen. Molekulare Virologie. 2. ed. Heidelberg-Berlin: Spektrum Akademischer Verlag GmbH 2003: 114-129
    Google Scholar
  • 2 Marshall D J, Reisdorf E, Harms G. et al . Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting.  J Clin Microbiol. 2007;  45 3875-3882
    CrossrefPubMedGoogle Scholar
  • 3 Borg I, Rohde G, Loeseke S. et al . Evaluation of a quantitative real-time PCR for the detection of RSV in pulmonary diseases.  Eur Respir J. 2003;  21 944-951
    CrossrefPubMedGoogle Scholar
  • 4 Ieven M. Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections.  J Clin Virol. 2007;  40 259-276
    CrossrefPubMedGoogle Scholar
  • 5 Stang A, Korn K, Wildner O. et al . Characterization of Virus Isolates by Particle-Associated Nucleic Acid PCR.  J Clin Microbiol. 2005;  43 716-720
    CrossrefPubMedGoogle Scholar
  • 6 Ambrose H E, Clewley J P. Virus discovery by sequence-independent genome amplification.  Rev Med Virol. 2006;  16 365-383
    CrossrefPubMedGoogle Scholar
  • 7 Janeway Jr C A, Travers P, Walport M. et al .D. Structure of the antibody molecule and the immunoglobulin genes. In: Janeway Jr. CA (ed). Immunobiology: the immune system in health and disease. 4. ed. London/New York: Elsevier Science Ltd/Garland Publishing 1999: 79-113
    Google Scholar
  • 8 Xiang X, Qiu D, Chan K P. et al . Comparison of three methods for respiratory virus detection between induced sputum and nasopharyngeal aspirate specimens in acute asthma.  J Virol Methods. 2002;  101 127-133
    CrossrefPubMedGoogle Scholar
  • 9 Beckham J D, Cadena A, Lin J. et al . Respiratory viral infections in patients with chronic, obstructive pulmonary disease.  J Infect. 2005;  50 322-330
    CrossrefPubMedGoogle Scholar
  • 10 Monto A S, Ullman B M. Acute respiratory illness in an American community. The Tecumseh study.  JAMA. 1974;  227 164-169
    CrossrefPubMedGoogle Scholar
  • 11 Macfarlane J, Holmes W, Gard P. et al . Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.  Thorax. 2001;  56 109-114
    CrossrefPubMedGoogle Scholar
  • 12 Meza R A, Bridges-Webb C, Sayer G P. The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990 – 1991.  Aust Fam Physician. 1994;  23 1550-1553
    PubMedGoogle Scholar
  • 13 Rohde G, Wiethege A, Borg I. et al . Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization – a case-control study.  Thorax. 2003;  58 37-42
    CrossrefPubMedGoogle Scholar
  • 14 Forster J, Ihorst G, Rieger C H. et al . Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study).  Eur J Pediatr. 2004;  163 709-716
    CrossrefPubMedGoogle Scholar
  • 15 Hoek L van der, Sure K, Ihorst G. et al . Croup is associated with the novel coronavirus NL63.  PLoS Med 2005. Aug ;  2 (8) e240
    Google Scholar
  • 16 Yap F H, Ho P L, Lam K F. et al . Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong.  J Med Virol. 2004;  73 617-623
    CrossrefPubMedGoogle Scholar
  • 17 Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis.  Chest. 2000;  117 380S-385S
    CrossrefPubMedGoogle Scholar
  • 18 Smith C B, Golden C A, Kanner R E. et al . Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases.  Am Rev Respir Dis. 1980;  121 225-232
    PubMedGoogle Scholar
  • 19 Gump D W, Phillips C A, Forsyth B R. et al . Role of infection in chronic bronchitis.  Am Rev Respir Dis. 1976;  113 465-474
    PubMedGoogle Scholar
  • 20 Buscho R O, Saxtan D, Shultz P S. et al . Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis.  J Infect Dis. 1978;  137 377-383
    CrossrefPubMedGoogle Scholar
  • 21 Seemungal T, Harper-Owen R, Bhowmik A. et al . Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease.  Am J Respir Crit Care Med. 2001;  164 1618-1623
    CrossrefPubMedGoogle Scholar
  • 22 Hutchinson A F, Ghimire A K, Thompson M A. et al . A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.  Respir Med. 2007;  101 2472-2481
    CrossrefPubMedGoogle Scholar
  • 23 Rohde G, Borg I, Arinir U. et al . Relevance of human metapneumovirus in exacerbations of COPD.  Respir Res. 2005;  6 : 150 doi 0.1186/1465-9921 – 6-150
    PubMedGoogle Scholar
  • 24 Hamelin M E, Cote S, Laforge J. et al . Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease.  Clin Infect Dis. 2005;  41 498-502
    CrossrefPubMedGoogle Scholar
  • 25 Martinello R A, Esper F, Weibel C. et al . Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease.  J Infect. 2006;  53 248-254
    CrossrefPubMedGoogle Scholar
  • 26 Wilkinson T M, Donaldson G C, Johnston S L. et al . Respiratory Syncytial Virus, Airway Inflammation and FEV1 Decline in Patients with COPD.  Am J Respir Crit Care Med. 2006;  173 871-876
    CrossrefPubMedGoogle Scholar
  • 27 Matsuse T, Hayashi S, Kuwano K. et al . Latent adenoviral infection in the pathogenesis of chronic airways obstruction.  Am Rev Respir Dis. 1992;  146 177-184
    CrossrefPubMedGoogle Scholar
  • 28 Retamales I, Elliott W M, Meshi B. et al . Amplification of inflammation in emphysema and its association with latent adenoviral infection.  Am J Respir Crit Care Med. 2001;  164 469-473
    CrossrefPubMedGoogle Scholar
  • 29 McManus T E, Marley A M, Baxter N. et al . Acute and latent adenovirus in COPD.  Respir Med. 2007;  101 2084-2090
    CrossrefPubMedGoogle Scholar
  • 30 Papadopoulos N G, Xepapadaki P, Mallia P. et al . Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA(2)LEN and InterAirways document.  Allergy. 200 726;  62 457-470
    PubMedGoogle Scholar
  • 31 Johnston S L, Pattemore P K, Sanderson G. et al . Community study of role of viral infections in exacerbations of asthma in 9 – 11 year old children.  BMJ. 1995;  310 1225-1229
    PubMedGoogle Scholar
  • 32 Nicholson K G, Kent J, Ireland D C. Respiratory viruses and exacerbations of asthma in adults.  BMJ. 1993;  307 982-986
    CrossrefPubMedGoogle Scholar
  • 33 Johnston S L, Pattemore P K, Sanderson G. et al . The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis.  Am J Respir Crit Care Med. 1996;  154 654-660
    PubMedGoogle Scholar
  • 34 Grunberg K, Timmers M C, de Klerk E P. et al . Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma.  Am J Respir Crit Care Med. 1999;  160 1375-1380
    PubMedGoogle Scholar
  • 35 Papadopoulos N G, Bates P J, Bardin P G. et al . Rhinoviruses infect the lower airways.  J Infect Dis. 2000;  181 1875-1884
    CrossrefPubMedGoogle Scholar
  • 36 Corne J M, Marshall C, Smith S. et al . Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.  Lancet. 2002;  359 831-834
    CrossrefPubMedGoogle Scholar
  • 37 Wark P A, Johnston S L, Bucchieri F. et al . Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.  J Exp Med. 2005;  201 937-947
    CrossrefPubMedGoogle Scholar
  • 38 de Roux A, Marcos M A, Garcia E. et al . Viral community-acquired pneumonia in nonimmunocompromised adults.  Chest. 2004;  125 1343-1351
    CrossrefPubMedGoogle Scholar
  • 39 Angeles M M, Camps M, Pumarola T. et al . The role of viruses in the aetiology of community-acquired pneumonia in adults.  Antivir Ther. 2006;  11 351-359
    PubMedGoogle Scholar
  • 40 Dowell S F, Anderson L J, Gary Jr H E. et al . Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults.  J Infect Dis. 1996;  174 456-462
    CrossrefPubMedGoogle Scholar
  • 41 Ruiz M, Ewig S, Marcos M A. et al . Etiology of community-acquired pneumonia in hospitalized patients: Impact of age, comorbidity and severity.  Am J Respir Crit Care Med. 1999;  160 397-405
    PubMedGoogle Scholar
  • 42 Krech T, Wegmann T, Martin H. et al . Etiology of atypical pneumonias. A serological study on 1494 patients.  Schweiz Med Wochenschr. 1986;  116 2-7
    PubMedGoogle Scholar
  • 43 Farr B M, Kaiser D L, Harrison B D. et al . Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee.  Thorax. 1989;  44 1031-1035
    CrossrefPubMedGoogle Scholar
  • 44 Dahmash N S, Chowdhury M N. Re-evaluation of pneumonia requiring admission to an intensive care unit: a prospective study.  Thorax. 1994;  49 71-76
    CrossrefPubMedGoogle Scholar
  • 45 Bohte R, Furth R van, Broek P J van den. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital.  Thorax. 1995;  50 543-547
    CrossrefPubMedGoogle Scholar
  • 46 Socan M, Marinic-Fiser N, Kraigher A. et al . Microbial aetiology of community-acquired pneumonia in hospitalised patients.  Eur J Clin Microbiol Infect Dis. 1999;  18 777-782
    CrossrefPubMedGoogle Scholar
  • 47 La S B, Marrie T J, Auffray J P. et al . Mimivirus in pneumonia patients.  Emerg Infect Dis. 2005;  11 449-542
    PubMedGoogle Scholar
  • 48 Woo P CY, Lau S KP, Tsoi H w. et al . Clinical and Molecular Epidemiological Features of Coronavirus HKU1-Associated Community-Acquired Pneumonia.  The Journal of Infectious Diseases. 20 051;  192 1898-1907
    PubMedGoogle Scholar
  • 49 Cebular S, Lee S, Tolaney P. et al . Community-acquired pneumonia in immunocompromised patients. Opportunistic infections to consider in differential diagnosis.  Postgrad Med. 2003;  113 65-70, 73
    CrossrefPubMedGoogle Scholar
  • 50 Duffau P, Moiton M P, Lafon M E. et al . A case of severe community acquired pneumonia and non-respiratory illness induced by Influenza A.  Med Mal Infect. 2006;  36 473-475
    CrossrefPubMedGoogle Scholar
  • 51 Lee N, Rainer T H, Ip M. et al . Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.  Eur J Clin Microbiol Infect Dis. 2006;  25 765-772
    CrossrefPubMedGoogle Scholar
  • 52 Jennings L C, Anderson T P, Beynon K A. et al . Incidence and Characteristics of Viral Community-Acquired Pneumonia in Adults.  Thorax. 2008;  63 42-48
    CrossrefPubMedGoogle Scholar
  • 53 Schlosser B, Rohde G, Borg I. et al . Viral and bacterial colonization in intubated patients in the ICU.  Proc Am Thorac Soc. 2005;  2 A822
    PubMedGoogle Scholar
  • 54 Daubin C, Parienti J J, Vincent S. et al . Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study.  Crit Care. 20 065;  10 R142
    PubMedGoogle Scholar
  • 55 Allander T, Tammi M T, Eriksson M. et al . Cloning of a human parvovirus by molecular screening of respiratory tract samples.  Proc Natl Acad Sci. 2005;  102 12 891-12 896
    PubMedGoogle Scholar
  • 56 Khetsuriani N, Kazerouni N N, Erdman D D. et al . Prevalence of viral respiratory tract infections in children with asthma.  Journal of Allergy and Clinical Immunology. 2007;  119 314-321
    CrossrefPubMedGoogle Scholar
  • 57 Kleines M, Scheithauer S, Rackowitz A. et al . High Prevalence of Human Bocavirus Detected in Young Children with Severe Acute Lower Respiratory Tract Disease by Use of a Standard PCR Protocol and a Novel Real-Time PCR Protocol.  J Clin Microbiol. 2007;  45 1032-104
    CrossrefPubMedGoogle Scholar
  • 58 Kupfer B, Vehreschild J, Cornely O. et al . Severe pneumonia and human bocavirus in adult.  Emerg Infect Dis. 2006;  12 1614-1616
    PubMedGoogle Scholar
  • 59 Allander T, Jartti T, Gupta S. et al . Human bocavirus and acute wheezing in children.  Clin Infect Dis. 2007;  44 904-910
    CrossrefPubMedGoogle Scholar
  • 60 Chung J Y, Han T H, Kim S W. et al . Detection of viruses identified recently in children with acute wheezing.  J Med Virol. 2007;  79 1238-1243
    CrossrefPubMedGoogle Scholar
  • 61 Fry A M, Lu X, Chittaganpitch M. et al . Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand.  J Infect Dis. 2007;  195 1038-1045
    CrossrefPubMedGoogle Scholar
  • 62 Gendrel D, Guedj R, Pons-Catalano C. et al . Human bocavirus in children with acute asthma.  Clin Infect Dis. 2007;  45 404-405
    CrossrefPubMedGoogle Scholar
  • 63 Kim Y J, Boeckh M, Englund J A. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.  Semin Respir Crit Care Med. 2007;  28 222-242
    Article in Thieme ConnectPubMedGoogle Scholar
  • 64 Lee J I, Chung J Y, Han T H. et al . Detection of human bocavirus in children hospitalized because of acute gastroenteritis.  J Infect Dis. 2007;  196 994-997
    CrossrefPubMedGoogle Scholar
  • 65 Lau S K, Yip C C, Que T L. et al . Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong.  J Infect Dis. 2007;  196 986-993
    CrossrefPubMedGoogle Scholar
  • 66 Vicente D, Cilla G, Montes M. et al . Human bocavirus, a respiratory and enteric virus.  Emerg Infect Dis. 2007;  13 636-637
    CrossrefPubMedGoogle Scholar
  • 67 Bastien N, Brandt K, Dust K. et al . Human Bocavirus infection, Canada.  Emerg Infect Dis. 2006;  12 848-850
    PubMedGoogle Scholar
  • 68 Kaplan N M, Dove W, Bu-Zeid A F. et al . Human bocavirus infection among children, Jordan.  Emerg Infect Dis. 2006;  12 1418-1420
    PubMedGoogle Scholar
  • 69 Neske F, Blessing K, Tollmann F. et al . Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis.  J Clin Microbiol. 2007;  45 2116-2122
    CrossrefPubMedGoogle Scholar
  • 70 Endo R, Ishiguro N, Kikuta H. et al . Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan.  J Clin Microbiol. 2007;  45 3218-3223
    CrossrefPubMedGoogle Scholar
  • 71 Allander T, Andreasson K, Gupta S. et al . Identification of a third human polyomavirus.  J Virol. 2007;  81 4130-4136
    CrossrefPubMedGoogle Scholar
  • 72 Bialasiewicz S, Whiley D M, Lambert S B. et al . A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children.  J Clin Virol. 2007;  40 15-18
    CrossrefPubMedGoogle Scholar
  • 73 Gaynor A M, Nissen M D, Whiley D M. et al . Identification of a novel polyomavirus from patients with acute respiratory tract infections.  PLoS Pathog. 2007;  3 e64
    CrossrefPubMedGoogle Scholar
  • 74 Norja P, Ubillos I, Templeton K. et al . No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease.  J Clin Virol. 2007;  40 307-311
    CrossrefPubMedGoogle Scholar
  • 75 Englund J A. Diagnosis and epidemiology of community-acquired respiratory virus infections in the immunocompromised host.  Biol Blood Marrow Transplant. 2001;  7 2S-4S
    CrossrefPubMedGoogle Scholar
  • 76 Couch R B, Englund J A, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons.  Am J Med. 1997;  102 2-9
    PubMedGoogle Scholar
  • 77 Barton T D, Blumberg E A. Viral pneumonias other than cytomegalovirus in transplant recipients.  Clin Chest Med. 2005;  26 707-720
    CrossrefPubMedGoogle Scholar
  • 78 Duncan A J, Dummer J S, Paradis I L. et al . Cytomegalovirus infection and survival in lung transplant recipients.  J Heart Lung Transplant. 1991;  10 638-644
    PubMedGoogle Scholar
  • 79 Ettinger N A, Bailey T C, Trulock E P. et al . Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group.  Am Rev Respir Dis. 1993;  147 1017-123
    PubMedGoogle Scholar
  • 80 Zamora M R, Davis R D, Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations.  Transplantation. 2005;  80 157-163
    CrossrefPubMedGoogle Scholar
  • 81 Humar A, Paya C, Pescovitz M D. et al . Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R− solid organ transplant recipients.  Am J Transplant. 2004;  4 644-649
    CrossrefPubMedGoogle Scholar
  • 82 Venard V, Carret A, Corsaro D. et al . Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved.  J Hosp Infect. 2000;  44 71-74
    CrossrefPubMedGoogle Scholar
  • 83 Ison M G. Adenovirus infections in transplant recipients.  Clin Infect Dis. 20 061;  43 331-339
    PubMedGoogle Scholar
  • 84 Runde V, Ross S, Trenschel R. et al . Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.  Bone Marrow Transplant. 2001;  28 51-57
    CrossrefPubMedGoogle Scholar
  • 85 Chakrabarti S, Mautner V, Osman H. et al . Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.  Blood. 2002;  100 1619-1627
    CrossrefPubMedGoogle Scholar
  • 86 Baldwin A, Kingman H, Darville M. et al . Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.  Bone Marrow Transplant. 2000;  26 1333-1338
    CrossrefPubMedGoogle Scholar
  • 87 Shields A F, Hackman R C, Fife K H. et al . Adenovirus infections in patients undergoing bone-marrow transplantation.  N Engl J Med. 1985;  312 529-533
    CrossrefPubMedGoogle Scholar
  • 88 Claas E C, Schilham M W, de Brouwer C S. et al . Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients.  J Clin Microbiol. 2005;  43 1738-1744
    CrossrefPubMedGoogle Scholar
  • 89 Kaiser L, Aubert J D, Pache J C. et al . Chronic rhinoviral infection in lung transplant recipients.  Am J Respir Crit Care Med. 2006;  174 1392-1399
    CrossrefPubMedGoogle Scholar
  • 90 Nichols W G, Guthrie K A, Corey L. et al . Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.  Clin Infect Dis. 2004;  39 1300-1306
    CrossrefPubMedGoogle Scholar
  • 91 Small T N, Casson A, Malak S F. et al . Respiratory syncytial virus infection following hematopoietic stem cell transplantation.  Bone Marrow Transplant. 2002;  29 321-327
    CrossrefPubMedGoogle Scholar
  • 92 Lee I, Barton T D. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management.  Drugs. 2007;  67 1411-1427
    CrossrefPubMedGoogle Scholar
  • 93 Kraaij M G van, Elden L J van, Loon A M van. et al . Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture.  Clin Infect Dis. 2005;  40 662-669
    CrossrefPubMedGoogle Scholar
  • 94 Rohde G. Therapeutic targets in respiratory viral infections.  Curr Med Chem. 2007;  14 2776-2782
    CrossrefPubMedGoogle Scholar

Jun.-Prof. PD Dr. med. Gernot Rohde

Medizinische Klinik III, Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH

Bürkle-de-la-Camp-Platz 1

44789 Bochum

Email: Gernot.Rohde@ruhr-uni-bochum.de